Exagen Inc. (XGN)

USD 5.52

(-4.83%)

Operating Expenses Summary of Exagen Inc.

  • Exagen Inc.'s latest annual operating expenses in 2023 was 52.29 Million USD , down -15.51% from previous year.
  • Exagen Inc.'s latest quarterly operating expenses in 2024 Q2 was 11.64 Million USD , up 0.36% from previous quarter.
  • Exagen Inc. reported a annual operating expenses of 61.89 Million USD in annual operating expenses 2022, up 19.54% from previous year.
  • Exagen Inc. reported a annual operating expenses of 51.77 Million USD in annual operating expenses 2021, up 27.53% from previous year.
  • Exagen Inc. reported a quarterly operating expenses of 11.6 Million USD for 2024 Q1, down -12.72% from previous quarter.
  • Exagen Inc. reported a quarterly operating expenses of 13.01 Million USD for 2023 Q1, down -16.13% from previous quarter.

Annual Operating Expenses Chart of Exagen Inc. (2023 - 2012)

Historical Annual Operating Expenses of Exagen Inc. (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 52.29 Million USD -15.51%
2022 61.89 Million USD 19.54%
2021 51.77 Million USD 27.53%
2020 40.6 Million USD 31.49%
2019 30.87 Million USD 40.73%
2018 21.94 Million USD 6.73%
2017 20.55 Million USD 0.0%
2015 19.06 Million USD 15.04%
2014 16.57 Million USD 104.5%
2013 8.1 Million USD 26.27%
2012 6.41 Million USD 0.0%

Peer Operating Expenses Comparison of Exagen Inc.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD 64.902%
Prenetics Global Limited 60.73 Million USD 13.902%
Star Equity Holdings, Inc. 16.27 Million USD -221.368%
CareDx, Inc 277.76 Million USD 81.174%
Exact Sciences Corporation 2.06 Billion USD 97.462%
Inotiv, Inc. 246.9 Million USD 78.82%
Guardant Health, Inc. 901.62 Million USD 94.2%
Biodesix, Inc. 77.41 Million USD 32.455%
BioNexus Gene Lab Corp. 3.92 Million USD -1232.956%
Precipio, Inc. 13.63 Million USD -283.436%
iSpecimen Inc. 16.27 Million USD -221.264%
Natera, Inc. 938.98 Million USD 94.431%
Aspira Women's Health Inc. 24.11 Million USD -116.857%
Standard BioTools Inc. 113.48 Million USD 53.922%
23andMe Holding Co. 420.73 Million USD 87.571%
Castle Biosciences, Inc. 242.78 Million USD 78.461%
Personalis, Inc. 128.14 Million USD 59.192%
Aclaris Therapeutics, Inc. 110.52 Million USD 52.687%
Applied DNA Sciences, Inc. 16.48 Million USD -217.183%
OpGen, Inc. 30.65 Million USD -70.569%
T2 Biosystems, Inc. 41.49 Million USD -26.025%
Myriad Genetics, Inc. 600.1 Million USD 91.286%
ICON Public Limited Company 755.64 Million USD 93.08%
NeoGenomics, Inc. 341.25 Million USD 84.676%
Star Equity Holdings, Inc. 16.27 Million USD -221.368%
IDEXX Laboratories, Inc. 1.09 Billion USD 95.215%
RadNet, Inc. 268.87 Million USD 80.551%
MDxHealth SA 71.25 Million USD 26.612%
Psychemedics Corporation 11.33 Million USD -361.382%
Illumina, Inc. 3.81 Billion USD 98.629%
Check-Cap Ltd. 19.28 Million USD -171.131%
Twist Bioscience Corporation 354.18 Million USD 85.235%
DarioHealth Corp. 62.17 Million USD 15.891%
Fulgent Genetics, Inc. 171.9 Million USD 69.58%
Sera Prognostics, Inc. 39.91 Million USD -31.004%
ENDRA Life Sciences Inc. 10.52 Million USD -397.047%
OPKO Health, Inc. 574.68 Million USD 90.901%
Medpace Holdings, Inc. 187.68 Million USD 72.137%
Neogen Corporation 405.23 Million USD 87.096%
Intelligent Bio Solutions Inc. 11.7 Million USD -346.613%
Prenetics Global Limited 60.73 Million USD 13.902%
Mainz Biomed B.V. 27.15 Million USD -92.577%
bioAffinity Technologies, Inc. 8.76 Million USD -496.622%
Trinity Biotech plc 46.49 Million USD -12.47%
Neuronetics, Inc. 82.25 Million USD 36.429%
Sotera Health Company 300.46 Million USD 82.596%
bioAffinity Technologies, Inc. 8.76 Million USD -496.622%